News
-
Aug 26, 2024MBL received MHLW approval for its MEBGEN™ mycobacterial nucleic acid identification kit
-
Jun 20, 2024MBL co-sponsors a seminar on MEBRIGHT™ genitalium Plus DR Kit at the 98th JAID / the 72nd JSC Conference
-
May 13, 2024MBL announces exclusive license agreement for Anti-Integrin αvβ6 Antibody with Immune-related Adverse Events colitis.
-
Mar 25, 2024MEBGEN™ BRAF 2 Kit Receives MHLW Approval as a Companion Diagnostic for Use with Patients with Thyroid Cancer